{"id":"W2121396361","doi":"10.1093/neuonc/nos273","title":"Standards of care for treatment of recurrent glioblastoma—are we there yet?","year":2012,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":771,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Temozolomide; Bevacizumab; Medicine; Oncology; Glioblastoma; Adjuvant; Concomitant; Clinical trial; Internal medicine; Standard of care; Radiation therapy; Chemotherapy; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000115254,0.0005579244,0.004307805,0.0002874767,0.00004515576,0.000003916774,0.0001394138,0.000523779,0.0001585579],"category_scores_gemma":[0.0000909311,0.0003282408,0.001270257,0.0002179443,0.0001174575,0.00002148061,0.00005439326,0.0001264579,0.00000993581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001489649,"about_ca_system_score_gemma":0.001217989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001088465,"about_ca_topic_score_gemma":0.0001279795,"domain_scores_codex":[0.9976193,0.0002343743,0.0009053917,0.0004774571,0.0003483303,0.0004151581],"domain_scores_gemma":[0.9967436,0.0008930525,0.001081897,0.000630673,0.0004379817,0.0002127953],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00046639,0.002322099,0.0001044235,0.02437035,0.0006939591,0.0001163838,0.0004227974,2.398822e-7,0.00002527861,0.00005530814,0.001694751,0.969728],"study_design_scores_gemma":[0.003477352,0.0272558,0.000009145275,0.006062287,0.008347885,0.000122866,0.0002041154,4.198378e-7,0.0008382957,0.000005794786,0.9534954,0.0001806547],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003083644,0.9913577,0.000002059341,0.0002863086,0.001067942,0.003680093,0.002666792,0.00002820077,0.0006025009],"genre_scores_gemma":[0.001328214,0.9966251,0.0001397398,0.00002048272,0.0002907269,0.001272671,0.0002066025,0.00009606402,0.00002035443],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9695474,"threshold_uncertainty_score":0.999917,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07411255517976502,"score_gpt":0.4022211541986221,"score_spread":0.3281085990188571,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}